The effects of L-Dopa on attention in Parkinson's disease and Parkinson's dementia patients

被引：0
|
作者：
Molloy, S
McKeith, IG
Burn, D
Wesnes, KA
机构：
[1] Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[2] Cognit Drug Res, Goring On Thames RG8 0EN, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2004年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [41] Amino acid supplementation in L-dopa treated Parkinson's disease patients
    Cucca, A.
    Mazzucco, S.
    Bursomanno, A.
    Antonutti, L.
    Di Girolamo, F. G.
    Pizzolato, G.
    Koscica, N.
    Gigli, G. L.
    Catalan, M.
    Biolo, G.
    CLINICAL NUTRITION, 2015, 34 (06) : 1189 - 1194
  • [42] Parkinson's patients treated with L-dopa: thirtieth anniversary of a new disease
    Cambier, J
    PRESSE MEDICALE, 1997, 26 (28): : 1347 - 1349
  • [43] Effect of L-DOPA and subthalamic surgery on proprioception in Parkinson's disease patients
    Merello, M
    Balej, J
    Aveleyra, C
    Leiguarda, R
    MOVEMENT DISORDERS, 2004, 19 : S358 - S358
  • [44] Correction to: Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients
    O. Bartošová
    C. Bonnet
    O. Ulmanová
    M. Šíma
    F. Perlík
    E. Růžička
    O. Slanař
    Journal of Neural Transmission, 2018, 125 : 1401 - 1401
  • [45] Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa
    De Bonis, Maria Luigia
    Tessitore, Alessandro
    Pellecchia, Maria Teresa
    Longo, Katia
    Salvatore, Anna
    Russo, Antonio
    Ingrosso, Diego
    Zappia, Vincenzo
    Barone, Paolo
    Galletti, Patrizia
    Tedeschi, Gioacchino
    NEUROSCIENCE LETTERS, 2010, 468 (03) : 287 - 291
  • [46] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    Heikkinen, H
    Nutt, JG
    LeWitt, PA
    Koller, WC
    Gordin, A
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
  • [47] Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose
    Ondo, William
    Coss, Pablo
    Christie, Melissa
    Pascual, Belen
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 153 - 156
  • [48] L-DOPA effects on laryngeal dysfunction in Parkinson's disease: An acoustic and aerodynamic study
    Viallet, F
    Jankowski, L
    Purson, A
    Teston, B
    MOVEMENT DISORDERS, 2004, 19 : S237 - S237
  • [49] Synergistic Effects Of L-dopa And Treadmill Exercise In A Mouse Model Of Parkinson's Disease
    Ju, Beomsoo
    Bledsoe, Dolton
    Cosio-Lima, Ludmila
    Mahmoudian, Armaghan
    Chung, Eunhee
    Lee, Youngil
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 369 - 369
  • [50] Psychophysiological approach in Parkinson's disease: L-dopa effects on preprogramming and control activity
    F. Fattapposta
    F. Pierelli
    F. My
    M. Mostarda
    S. Del Monte
    L. Parisi
    M. Serrao
    N. Locuratolo
    G. Amabile
    Neurological Sciences, 2002, 23 : s73 - s74
12345